The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Interleukin 33 is a guardian of barriers and a local alarmin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
Moussion, C., Ortega, N., & Girard, J.-P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003331 · Cited by 1,179
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. J., & Lee, R. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30634 · Cited by 1,044
The alarmin IL-33 promotes regulatory T-cell function in the intestine
Schiering, C., Krausgruber, T., Chomka, A., Fröhlich, A., Adelmann, K., Wohlfert, E. A., Pott, J., Griseri, T., Bollrath, J., Hegazy, A. N., et al. (2014) · Nature · doi:10.1038/nature13577 · Cited by 1,005
Disease-associated functions of IL-33: the new kid in the IL-1 family
Liew, F. Y., Pitman, N. I., & McInnes, I. B. (2010) · Nature Reviews Immunology · doi:10.1038/nri2692 · Cited by 1,003
Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606854104 · Cited by 966
Hu, X., & Ivashkiv, L. B. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.002 · Cited by 928
Barrier Epithelial Cells and the Control of Type 2 Immunity
Hammad, H., & Lambrecht, B. N. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.007 · Cited by 847
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Cayrol, C., & Girard, J.-P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812690106 · Cited by 707
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Lüthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G., Taylor, R. C., Kersse, K., Vandenabeele, P., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.007 · Cited by 677
IL-33 is a crucial amplifier of innate rather than acquired immunity
Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A., Abe, T., Kiyonari, H., Matsumoto, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003059107 · Cited by 652
Löhning, M., Stroehmann, A., Coyle, A. J., Grogan, J. L., Lin, S., Gutierrez-Ramos, J.-C., Levinson, D., Radbruch, A., & Kamradt, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6930 · Cited by 605
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Lefrançais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J.-P., & Cayrol, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115884109 · Cited by 594
RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
Rickard, J. A., O’Donnell, J. A., Evans, J. M., Lalaoui, N., Poh, A. R., Rogers, T., Vince, J. E., Lawlor, K. E., Ninnis, R. L., Anderton, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.019 · Cited by 593
Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation
Hayakawa, H., Hayakawa, M., Kume, A., & Tominaga, S.-I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704916200 · Cited by 546
Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells
Préfontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R., Halayko, A. J., Lemière, C., Martin, J. G., & Hamid, Q. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802387 · Cited by 538
Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells
Xu, D., Chan, W. L., Leung, B. P., Huang, F.-P., Wheeler, R., Piedrafita, D., Robinson, J. H., & Liew, F. Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.787 · Cited by 512
IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex
Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S., & Kastelein, R. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2551 · Cited by 508
Kouzaki, H., Iijima, K., Kobayashi, T., O’Grady, S. M., & Kita, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003020 · Cited by 495
Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
Afonina, I. S., Müller, C., Martin, S. J., & Beyaert, R. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.003 · Cited by 490
Townsend, M. J., Fallon, P. G., Matthews, D. J., Jolin, H. E., & McKenzie, A. N. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.1069 · Cited by 482
Baekkevold, E. S., Roussigné, M., Yamanaka, T., Johansen, F.-E., Jahnsen, F. L., Amalric, F., Brandtzaeg, P., Erard, M., Haraldsen, G., & Girard, J.-P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63631-0 · Cited by 474
Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N., & Girard, J.-P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101977 · Cited by 466
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Xu, D., Jiang, H.-R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N., Kurowska-Stolarska, M., McKenzie, A. N. J., McInnes, I. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801898105 · Cited by 464
Increased IL-33 expression by epithelial cells in bronchial asthma
Préfontaine, D., Nadigel, J., Chouiali, F., Audusseau, S., Semlali, A., Chakir, J., Martin, J. G., & Hamid, Q. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.12.935 · Cited by 454
Palomo, J., Dietrich, D., Martin, P., Palmer, G., & Gabay, C. (2015) · Cytokine · doi:10.1016/j.cyto.2015.06.017 · Cited by 447
The Alarmin Interleukin-33 Drives Protective Antiviral CD8 + T Cell Responses
Bonilla, W. V., Fröhlich, A., Senn, K., Kallert, S., Fernandez, M., Johnson, S., Kreutzfeldt, M., Hegazy, A. N., Schrick, C., Fallon, P. G., et al. (2012) · Science · doi:10.1126/science.1215418 · Cited by 417
IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells
Guo, L., Wei, G., Zhu, J., Liao, W., Leonard, W. J., Zhao, K., & Paul, W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906988106 · Cited by 417
Shimpo, M., Morrow, D. A., Weinberg, E. O., Sabatine, M. S., Murphy, S. A., Antman, E. M., & Lee, R. T. (2004) · Circulation · doi:10.1161/01.cir.0000127958.21003.5a · Cited by 411
Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation
Williams, J. W., Tjota, M. Y., Clay, B. S., Vander Lugt, B., Bandukwala, H. S., Hrusch, C. L., Decker, D. C., Blaine, K. M., Fixsen, B. R., Singh, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms3990 · Cited by 402
IL-33–activated dendritic cells induce an atypical TH2-type response
Rank, M. A., Kobayashi, T., Kozaki, H., Bartemes, K. R., Squillace, D. L., & Kita, H. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.026 · Cited by 399
Tominaga, S.-I. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81679-5 · Cited by 385
Lefrançais, E., Duval, A., Mirey, E., Roga, S., Espinosa, E., Cayrol, C., & Girard, J.-P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410700111 · Cited by 384
Coyle, A. J., Lloyd, C., Tian, J., Nguyen, T., Erikkson, C., Wang, L., Ottoson, P., Persson, P., Delaney, T., Lehar, S., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.895 · Cited by 370
Gadani, S. P., Walsh, J. T., Smirnov, I., Zheng, J., & Kipnis, J. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.013 · Cited by 359
Long-term IL-33–producing epithelial progenitor cells in chronic obstructive lung disease
Byers, D. E., Alexander-Brett, J., Patel, A. C., Agapov, E., Dang-Vu, G., Jin, X., Wu, K., You, Y., Alevy, Y., Girard, J.-P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65570 · Cited by 337
IL‐33‐activated dendritic cells are critical for allergic airway inflammation
Besnard, A., Togbe, D., Guillou, N., Erard, F., Quesniaux, V., & Ryffel, B. (2011) · European Journal of Immunology · doi:10.1002/eji.201041033 · Cited by 331
Ali, S., Huber, M., Kollewe, C., Bischoff, S. C., Falk, W., & Martin, M. U. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705939104 · Cited by 325
Self-citationAli, S., Mohs, A., Thomas, M., Klare, J., Ross, R., Schmitz, M. L., & Martin, M. U. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003080 · Cited by 324
Self-citationThe Biology of ST2: The International ST2 Consensus Panel
Pascual-Figal, D. A., & Januzzi, J. L. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.034 · Cited by 319
Kim, H. Y., Chang, Y.-J., Subramanian, S., Lee, H.-H., Albacker, L. A., Matangkasombut, P., Savage, P. B., McKenzie, A. N. J., Smith, D. E., Rottman, J. B., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.036 · Cited by 316
Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis
Palmer, G., Talabot‐Ayer, D., Lamacchia, C., Toy, D., Seemayer, C. A., Viatte, S., Finckh, A., Smith, D. E., & Gabay, C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24305 · Cited by 313
Interleukin-33 – cytokine of dual function or novel alarmin?
Haraldsen, G., Balogh, J., Pollheimer, J., Sponheim, J., & Küchler, A. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.003 · Cited by 308
Localisation and trafficking of Toll-like receptors: an important mode of regulation
McGettrick, A. F., & O’Neill, L. A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.12.002 · Cited by 307
Growth factor-induced delayed early response genes.
Lanahan, A., Williams, J. B., Sanders, L. K., & Nathans, D. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.3919 · Cited by 303
Roussel, L., Erard, M., Cayrol, C., & Girard, J. (2008) · EMBO reports · doi:10.1038/embor.2008.145 · Cited by 300
Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells
Kakkar, R., Hei, H., Dobner, S., & Lee, R. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298703 · Cited by 297
Morita, H., Arae, K., Unno, H., Miyauchi, K., Toyama, S., Nambu, A., Oboki, K., Ohno, T., Motomura, K., Matsuda, A., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.021 · Cited by 274
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Cohen, E. S., Scott, I. C., Majithiya, J. B., Rapley, L., Kemp, B. P., England, E., Rees, D. G., Overed-Sayer, C. L., Woods, J., Bond, N. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9327 · Cited by 270
The role of the nucleosome acidic patch in modulating higher order chromatin structure
Kalashnikova, A. A., Porter-Goff, M. E., Muthurajan, U. M., Luger, K., & Hansen, J. C. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.1022 · Cited by 269
Divekar, R., & Kita, H. (2015) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0000000000000133 · Cited by 255
Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage
Talabot-Ayer, D., Lamacchia, C., Gabay, C., & Palmer, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901744200 · Cited by 252
Turnquist, H. R., Zhao, Z., Rosborough, B. R., Liu, Q., Castellaneta, A., Isse, K., Wang, Z., Lang, M., Beer Stolz, D., Zheng, X. X., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100519 · Cited by 245
IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation
Hsu, C.-L., Neilsen, C. V., & Bryce, P. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011944 · Cited by 236
Moritz, D. R., Rodewald, H.-R., Gheyselinck, J., & Klemenz, R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4866 · Cited by 233
The interleukin-1 receptor family
Boraschi, D., & Tagliabue, A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.023 · Cited by 227
Production and functions of IL-33 in the central nervous system
Yasuoka, S., Kawanokuchi, J., Parajuli, B., Jin, S., Doi, Y., Noda, M., Sonobe, Y., Takeuchi, H., Mizuno, T., & Suzumura, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.045 · Cited by 222
Küchler, A. M., Pollheimer, J., Balogh, J., Sponheim, J., Manley, L., Sorensen, D. R., De Angelis, P. M., Scott, H., & Haraldsen, G. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080014 · Cited by 220
Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma
Liu, X., Li, M., Wu, Y., Zhou, Y., Zeng, L., & Huang, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.008 · Cited by 219
Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T., & Tominaga, S.-I. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81333-u · Cited by 219
Matta, B. M., Lott, J. M., Mathews, L. R., Liu, Q., Rosborough, B. R., Blazar, B. R., & Turnquist, H. R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400481 · Cited by 216
Structural insights into the interaction of IL-33 with its receptors
Liu, X., Hammel, M., He, Y., Tainer, J. A., Jeng, U.-S., Zhang, L., Wang, S., & Wang, X. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308651110 · Cited by 213
Induction of IL-33 expression and activity in central nervous system glia
Hudson, C. A., Christophi, G. P., Gruber, R. C., Wilmore, J. R., Lawrence, D. A., & Massa, P. T. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1207830 · Cited by 213
Lingel, A., Weiss, T. M., Niebuhr, M., Pan, B., Appleton, B. A., Wiesmann, C., Bazan, J. F., & Fairbrother, W. J. (2009) · Structure · doi:10.1016/j.str.2009.08.009 · Cited by 212
Interleukin-33 biology with potential insights into human diseases
Palmer, G., & Gabay, C. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.53 · Cited by 206
Barreyro, L., Will, B., Bartholdy, B., Zhou, L., Todorova, T. I., Stanley, R. F., Ben-Neriah, S., Montagna, C., Parekh, S., Pellagatti, A., et al. (2012) · Blood · doi:10.1182/blood-2012-01-404699 · Cited by 201
Hoshino, K., Kashiwamura, S.-I., Kuribayashi, K., Kodama, T., Tsujimura, T., Nakanishi, K., Matsuyama, T., Takeda, K., & Akira, S. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1541 · Cited by 201
Järås, M., Johnels, P., Hansen, N., Ågerstam, H., Tsapogas, P., Rissler, M., Lassen, C., Olofsson, T., Bjerrum, O. W., Richter, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004408107 · Cited by 185
IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes
Wood, I. S., Wang, B., & Trayhurn, P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.081 · Cited by 182
Palmer, G., Lipsky, B. P., Smithgall, M. D., Meininger, D., Siu, S., Talabot-Ayer, D., Gabay, C., & Smith, D. E. (2008) · Cytokine · doi:10.1016/j.cyto.2008.03.008 · Cited by 180
Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1
Spooner, C. J., Lesch, J., Yan, D., Khan, A. A., Abbas, A., Ramirez-Carrozzi, V., Zhou, M., Soriano, R., Eastham-Anderson, J., Diehl, L., et al. (2013) · Nature Immunology · doi:10.1038/ni.2743 · Cited by 176
Sattler, S., Ling, G.-S., Xu, D., Hussaarts, L., Romaine, A., Zhao, H., Fossati-Jimack, L., Malik, T., Cook, H. T., Botto, M., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.032 · Cited by 173
Sponheim, J., Pollheimer, J., Olsen, T., Balogh, J., Hammarström, C. L., Loos, T., Kasprzycka, M., Sørensen, D. R., Nilsen, H. R., Küchler, A. M., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100378 · Cited by 172
T-bet– and STAT4–dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses
Baumann, C., Bonilla, W. V., Fröhlich, A., Helmstetter, C., Peine, M., Hegazy, A. N., Pinschewer, D. D., & Löhning, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418549112 · Cited by 169
Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation
Bessa, J., Meyer, C. A., de Vera Mudry, M. C., Schlicht, S., Smith, S. H., Iglesias, A., & Cote-Sierra, J. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.02.012 · Cited by 169
IL‐33 induces skin inflammation with mast cell and neutrophil activation
Hueber, A. J., Alves‐Filho, J. C., Asquith, D. L., Michels, C., Millar, N. L., Reilly, J. H., Graham, G. J., Liew, F. Y., Miller, A. M., & McInnes, I. B. (2011) · European Journal of Immunology · doi:10.1002/eji.201041360 · Cited by 167
Klemenz, R., Hoffmann, S., & Werenskiold, A. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5708 · Cited by 166
The IL-33/ST2 pathway — A new therapeutic target in cardiovascular disease
Miller, A. M., & Liew, F. Y. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.02.005 · Cited by 165
Onda, H., Kasuya, H., Takakura, K., Hori, T., Imaizumi, T.-A., Takeuchi, T., Inoue, I., & Takeda, J. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199911000-00013 · Cited by 165
Demyanets, S., Kaun, C., Pentz, R., Krychtiuk, K. A., Rauscher, S., Pfaffenberger, S., Zuckermann, A., Aliabadi, A., Gröger, M., Maurer, G., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.03.020 · Cited by 165
IL-33 activates tumor stroma to promote intestinal polyposis
Maywald, R. L., Doerner, S. K., Pastorelli, L., Salvo, C. D., Benton, S. M., Dawson, E. P., Lanza, D. G., Berger, N. A., Markowitz, S. D., Lenz, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422445112 · Cited by 159
Caspase-1, Caspase-8, and Calpain Are Dispensable for IL-33 Release by Macrophages
Ohno, T., Oboki, K., Kajiwara, N., Morii, E., Aozasa, K., Flavell, R. A., Okumura, K., Saito, H., & Nakae, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802449 · Cited by 159
Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33
Chen, W.-Y., Hong, J., Gannon, J., Kakkar, R., & Lee, R. T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424236112 · Cited by 158
Rider, P., Carmi, Y., Voronov, E., & Apte, R. N. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.005 · Cited by 155
Crystal structure of the cytokine interleukin‐1 beta.
Priestle, J. P., Schär, H., & Grütter, M. G. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02818.x · Cited by 152
Zhao, J., Wei, J., Mialki, R. K., Mallampalli, D., Chen, B. B., Coon, T. A., Zou, C., Mallampalli, R. K., & Zhao, Y. (2012) · Nature Immunology · doi:10.1038/ni.2341 · Cited by 152
IL-33 is upregulated in colonocytes of ulcerative colitis
Seidelin, J. B., Bjerrum, J. T., Coskun, M., Widjaya, B., Vainer, B., & Nielsen, O. H. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.11.001 · Cited by 147
Expression and regulation of interleukin‐33 in human monocytes
Nile, C. J., Barksby, E., Jitprasertwong, P., Preshaw, P. M., & Taylor, J. J. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03221.x · Cited by 145
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease
Lopetuso, L. R., Chowdhry, S., & Pizarro, T. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00181 · Cited by 139
Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation
Choi, Y.-S., Park, J. A., Kim, J., Rho, S.-S., Park, H., Kim, Y., & Kwon, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.005 · Cited by 139
Louten, J., Rankin, A. L., Li, Y., Murphy, E. E., Beaumont, M., Moon, C., Bourne, P. A., McClanahan, T. K., Pflanz, S., & Malefyt, R. D. W. (2011) · International Immunology · doi:10.1093/intimm/dxr006 · Cited by 136
Roy, A., Ganesh, G., Sippola, H., Bolin, S., Sawesi, O., Dagälv, A., Schlenner, S., Feyerabend, T. B., Rodewald, H.-R., Kjellén, L., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435156 · Cited by 133
The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells
Drube, S., Heink, S., Walter, S., Löhn, T., Grusser, M., Gerbaulet, A., Berod, L., Drube, J., Dudeck, A., Freitag, J., et al. (2010) · Blood · doi:10.1182/blood-2009-10-247411 · Cited by 129
Meephansan, J., Tsuda, H., Komine, M., Tominaga, S., & Ohtsuki, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.185 · Cited by 128
Byrne, S. N., Beaugie, C., O’Sullivan, C., Leighton, S., & Halliday, G. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.010 · Cited by 126
Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists
Polumuri, S. K., Jayakar, G. G., Shirey, K. A., Roberts, Z. J., Perkins, D. J., Pitha, P. M., & Vogel, S. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1003554 · Cited by 125
IL-33 Activates B1 Cells and Exacerbates Contact Sensitivity
Komai‐Koma, M., Gilchrist, D. S., McKenzie, A. N. J., Goodyear, C. S., Xu, D., & Liew, F. Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002103 · Cited by 121
Lefrançais, E., & Cayrol, C. (2012) · European Cytokine Network · doi:10.1684/ecn.2012.0320 · Cited by 117
The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders
Saluja, R., Ketelaar, M. E., Hawro, T., Church, M. K., Maurer, M., & Nawijn, M. C. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.018 · Cited by 113
Liew, F. Y. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200589 · Cited by 109
Mast Cells Respond to Cell Injury through the Recognition of IL-33
Lunderius-Andersson, C., Enoksson, M., & Nilsson, G. P. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00082 · Cited by 109
Madouri, F., Guillou, N., Fauconnier, L., Marchiol, T., Rouxel, N., Chenuet, P., Ledru, A., Apétoh, L., Ghiringhelli, F., Chamaillard, M., et al. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv012 · Cited by 106
Ali, S., Nguyen, D. Q., Falk, W., & Martin, M. U. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.107 · Cited by 105
Self-citationNegative regulatory receptors of the IL-1 family
Garlanda, C., Riva, F., Bonavita, E., & Mantovani, A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.019 · Cited by 103
The enigmatic processing and secretion of interleukin-33
Zhao, W., & Hu, Z. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.3 · Cited by 103
Soluble ST2—Analytical Considerations
Mueller, T., & Jaffe, A. S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.035 · Cited by 103
Intraperitoneal influx of neutrophils in response to IL-33 is mast cell–dependent
Enoksson, M., Möller-Westerberg, C., Wicher, G., Fallon, P. G., Forsberg‐Nilsson, K., Lunderius-Andersson, C., & Nilsson, G. P. (2012) · Blood · doi:10.1182/blood-2012-05-434209 · Cited by 103
Gächter, T., Werenskiold, A. K., & Klemenz, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.124 · Cited by 101
Sugita, S., Hosaka, Y., Okada, K., Mori, D., Yano, F., Kobayashi, H., Taniguchi, Y., Mori, Y., Okuma, T., Chang, S. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419699112 · Cited by 100
Superti‐Furga, G., Bergers, G., Picard, D., & Busslinger, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5114 · Cited by 93
TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium
Zhang, L., Lu, R., Zhao, G., Pflugfelder, S. C., & Li, D. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.06.003 · Cited by 93
Li, C., Li, H., Jiang, Z., Zhang, T., Wang, Y., Li, Z., Wu, Y., Ji, S., Xiao, S., Ryffel, B., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003918 · Cited by 92
Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice
Zhiguang, X., Chen, W., Steven, R., Dong, W., Zhang, W., Mu, R., Zhanguo, L., & Zhang, L. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.04.005 · Cited by 85
Su, Z., Lin, J., Lü, F., Zhang, X., Zhang, L., Gandhi, N. B., de Paiva, C. S., Pflugfelder, S. C., & Li, D.-Q. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.130 · Cited by 85
Special aspects of interleukin-33 and the IL-33 receptor complex
Martin, M. U. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.006 · Cited by 83
Self-citationShao, D., Perros, F., Caramori, G., Meng, C., Dormuller, P., Chou, P.-C., Church, C., Papi, A. A., Casolari, P., Welsh, D., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.111 · Cited by 83
The Alarmin IL-33 Is a Notch Target in Quiescent Endothelial Cells
Sundlisæter, E., Edelmann, R. J., Fosse, J. H., Sponheim, J., Küchler, A. M., Weiss, M., Udalova, I. A., Midwood, K. S., Kasprzycka, M., & Haraldsen, G. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.003 · Cited by 82
Kempuraj, D., Khan, M. M., Thangavel, R., Xiong, Z., Yang, E., & Zaheer, A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9439-7 · Cited by 81
Schmieder, A., Multhoff, G., & Radons, J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.06.286 · Cited by 77
Expression of IL-33 in the epidermis: The mechanism of induction by IL-17
Meephansan, J., Komine, M., Tsuda, H., Karakawa, M., Tominaga, S., & Ohtsuki, M. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.04.014 · Cited by 77
Identification of Constitutively Active Interleukin 33 (IL-33) Splice Variant
Hong, J., Bae, S., Jhun, H., Lee, S., Choi, J., Kang, T., Kwak, A., Hong, K., Kim, E., Jo, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219089 · Cited by 76
Evidence for a regulatory loop between IFN‐γ and IL‐33 in skin inflammation
Seltmann, J., Werfel, T., & Wittmann, M. (2012) · Experimental Dermatology · doi:10.1111/exd.12076 · Cited by 74
Sundnes, O., Pietka, W., Loos, T., Sponheim, J., Rankin, A. L., Pflanz, S., Bertelsen, V., Sitek, J. C., Fosse, J. H., Haraldsen, G., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.85 · Cited by 72
TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis
Arshad, M. I., Piquet‐Pellorce, C., L’Helgoualc’h, A., Rauch, M., Patrat-Delon, S., Ezan, F., Lucas‐Clerc, C., Nabti, S., Lehuen, A., Cubero, F. J., et al. (2012) · Hepatology · doi:10.1002/hep.25893 · Cited by 70
Quantitative phosphoproteomic analysis of IL‐33‐mediated signaling
Pinto, S. M., Nirujogi, R. S., Rojas, P. L., Patil, A. H., Manda, S. S., Subbannayya, Y., Roa, J. C., Chatterjee, A., Prasad, T. S. K., & Pandey, A. (2014) · PROTEOMICS · doi:10.1002/pmic.201400303 · Cited by 69
Arshad, M. I., Rauch, M., L’Helgoualc’h, A., Julia, V., Leite‐de‐Moraes, M., Lucas‐Clerc, C., Piquet‐Pellorce, C., & Samson, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041332 · Cited by 69
IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling
Saïdi, S., Bouri, F., Lencel, P., Duplomb, L., Baud’huin, M., Delplace, S., Leterme, D., Miellot, F., Heymann, D., Hardouin, P., et al. (2010) · Cytokine · doi:10.1016/j.cyto.2010.11.021 · Cited by 67
Talabot‐Ayer, D., Calo, N., Vigne, S., Lamacchia, C., Gabay, C., & Palmer, G. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811425 · Cited by 64
Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells
Yanagawa, Y., Matsumoto, M., & Togashi, H. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.04.012 · Cited by 63
Expression of IL ‐33 and its epigenetic regulation in multiple sclerosis
Zhang, F., Tossberg, J. T., Spurlock, C. F., Yao, S., Aune, T. M., & Sriram, S. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.47 · Cited by 62
AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites
Kim, L. K., Morita, R., Kobayashi, Y., Eisenbarth, S. C., Lee, C. G., Elias, J. A., Eynon, E. E., & Flavell, R. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507393112 · Cited by 60
The GOLD Domain-containing Protein TMED1 Is Involved in Interleukin-33 Signaling*
Connolly, D. J., O'Neill, L. A. J., & McGettrick, A. F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.403899 · Cited by 55
Kurokawa, M., Matsukura, S., Kawaguchi, M., Ieki, K., Suzuki, S., Odaka, M., Watanabe, S., Homma, T., Sato, M., Yamaguchi, M., et al. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000327259 · Cited by 54
Pollheimer, J., Bodin, J., Sundnes, O., Edelmann, R. J., Skånland, S. S., Sponheim, J., Brox, M. J., Sundlisæter, E., Loos, T., Vatn, M., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.253427 · Cited by 54
Tjota, M. Y., Hrusch, C. L., Blaine, K. M., Williams, J. W., Barrett, N. A., & Sperling, A. I. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.013 · Cited by 53
IFN-γ Directly Controls IL-33 Protein Level through a STAT1- and LMP2-dependent Mechanism
Kopach, P., Lockatell, V., Pickering, E. M., Haskell, R. E., Anderson, R. D., Hasday, J. D., Todd, N. W., Luzina, I. G., & Atamas, S. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534396 · Cited by 50
Zhang, H., Xie, S., Chen, Y., Mai, J., Wang, J., Zhu, W.-L., & Li-guang, Z. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-120 · Cited by 50
Bianchetti, L., Marini, M. A., Isgrò, M., Bellini, A., Schmidt, M., & Mattoli, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.047 · Cited by 49
Paris, G., Pozharskaya, T., Asempa, T. E., & Lane, A. P. (2013) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21237 · Cited by 49
Nomura, K., Kojima, T., Fuchimoto, J., Obata, K., Keira, T., Himi, T., & Sawada, N. (2012) · The Laryngoscope · doi:10.1002/lary.23261 · Cited by 46
Lei, Y., Boinapally, V., Zoltowska, A., Adner, M., Hellman, L., & Nilsson, G. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133774 · Cited by 45
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency
Martin, P., Talabot‐Ayer, D., Seemayer, C. A., Vigne, S., Lamacchia, C., Rodriguez, E., Finckh, A., Smith, D. E., Gabay, C., & Palmer, G. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4143 · Cited by 43
Liang, Y., Jie, Z., Hou, L., Yi, P., Wang, W., Kwota, Z., Salvato, M. S., Malefyt, R. D. W., Soong, L., & Sun, J. (2015) · European Journal of Immunology · doi:10.1002/eji.201545696 · Cited by 38
Epithelial-derived nuclear IL-33 aggravates inflammation in the pathogenesis of reflux esophagitis
Shan, J., Oshima, T., Muto, T., Yasuda, K., Fukui, H., Watari, J., Nakanishi, K., & Miwa, H. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0988-1 · Cited by 36
Novel Splice Variants of IL-33: Differential Expression in Normal and Transformed Cells
Tsuda, H., Komine, M., Karakawa, M., Etoh, T., Tominaga, S., & Ohtsuki, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.180 · Cited by 36
Talabot‐Ayer, D., Martin, P., Vesin, C., Seemayer, C. A., Vigne, S., Gabay, C., & Palmer, G. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402057 · Cited by 34
Prostaglandin E2 enhances IL-33 production by dendritic cells
Yanagawa, Y., Suzuki, M., Matsumoto, M., & Togashi, H. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.07.005 · Cited by 34
Arshad, M. I., Patrat-Delon, S., Piquet‐Pellorce, C., L’Helgoualc’h, A., Rauch, M., Genêt, V., Lucas‐Clerc, C., Bleau, C., Lamontagne, L., & Samson, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074278 · Cited by 32
ST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosis
Lee, J. S., Seppanen, E. J., Patel, J., Rodero, M. P., & Khosrotehrani, K. (2015) · Experimental Dermatology · doi:10.1111/exd.12833 · Cited by 30
Zhao, J., Wei, J., Bowser, R. K., Traister, R. S., Fan, M.-H., & Zhao, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401414 · Cited by 28
Immune-mediated experimental arthritis in IL-33 deficient mice
Talabot‐Ayer, D., Martin, P., Seemayer, C. A., Vigne, S., Lamacchia, C., Finckh, A., Saïji, E., Gabay, C., & Palmer, G. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.007 · Cited by 25
Deubiquitination and stabilization of IL-33 by USP21.
Tao, L., Chen, C., Song, H., Piccioni, M., Shi, G., & Li, B. (2014) · Europe PMC (PubMed Central) · Cited by 23
IL-33 Enhanced the Proliferation and Constitutive Production of IL-13 and IL-5 by Fibrocytes
Hayashi, H., Kawakita, A., Okazaki, S., Murai, H., Yasutomi, M., & Ohshima, Y. (2014) · BioMed Research International · doi:10.1155/2014/738625 · Cited by 22
Ahmed, A., & Komai‐Koma, M. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12312 · Cited by 21
Up-regulation of IL-33 expression in various types of murine cells by IL-3 and IL-4
Zhao, W., & Hu, Z. (2012) · Cytokine · doi:10.1016/j.cyto.2012.01.019 · Cited by 20
IL‐33 broadens its repertoire to affect DC
Turnquist, H. R., & Thomson, A. W. (2009) · European Journal of Immunology · doi:10.1002/eji.200940026 · Cited by 20
Holtzman, M. J., Byers, D. E., Brett, J.-A., Patel, A. C., Agapov, E. V., Jin, X., & Wu, K. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201402-056aw · Cited by 15
Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200007)30:7 · Cited by 1
Cited by
Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis
Chen, Z., Bozec, A., Ramming, A., & Schett, G. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0109-2 · Cited by 719
Mack, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 514
Dying cells actively regulate adaptive immune responses
Yatim, N., Cullen, S., & Albert, M. L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.9 · Cited by 442
Yang, D., Han, Z., & Oppenheim, J. J. (2017) · Immunological Reviews · doi:10.1111/imr.12577 · Cited by 405
The family of the interleukin‐1 receptors
Boraschi, D., Italiani, P., Weil, S., & Martin, M. U. (2018) · Immunological Reviews · doi:10.1111/imr.12606 · Cited by 389
Self-citation
Metadata
- Authors
- Martin, N. T., & Martin, M. U.
- Venue
- Nature Immunology
- Published
- 2016-01-19
- Volume
- 17
- Issue
- 2
- Pages
- 122-131
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2270215994
- Cited by
- 408
- References
- 159
- FWCI
- 29.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.